ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,402, issued on Sept. 30, was assigned to CRYSTAL PHARMACEUTICAL (SUZHOU) Co. LTD. (Suzhou, China).
"Resmetirom crystal, preparation method for same, and uses thereof" was invented by Minhua Chen (Suzhou, China) and Xingjuan Chang (Suzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Novel crystalline forms of Resmetirom (Referred to as "Compound I"), and preparation methods thereof, pharmaceutical compositions containing the crystalline forms, and uses of the crystalline forms for preparing THR-Beta selective agonist drugs and drugs for treating NASH and HeFH. Compared with prior arts, the provided crystalline forms of Compound I have one o...